A Retrospective Study of Serum Indicators in Functional High-Risk Multiple Myeloma Patients Undertaking Proteasome Inhibitors Treatments

被引：0
|
作者：
Zhan, Linquan [1 ]
Yuan, Dai [1 ]
Ge, Xueling [1 ]
Ding, Mei [1 ]
Zhou, Xiangxiang [1 ]
Wang, Xin [1 ]
机构：
[1] Shandong Prov Hosp, Dept Hematol, Shandong, Peoples R China
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-378
引用
收藏
页码：S251 / S251
页数：1
相关论文
共 50 条
  • [31] Identification of high-risk patients in multiple myeloma using a clonal gene signature
    Li, Jian-Rong
    Wang, Christiana
    Cheng, Chao
    CANCER RESEARCH, 2024, 84 (06)
  • [32] Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma
    Richardson, Paul G.
    Sonneveld, Pieter
    Schuster, Michael W.
    Irwin, David
    Stadtmauer, Edward A.
    Facon, Thierry
    Harousseau, Jean-Luc
    Ben-Yehuda, Dina
    Lonial, Sagar
    San Miguel, Jesus-F.
    Cavenagh, Jamie D.
    Anderson, Kenneth C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (05) : 429 - 435
  • [33] Current Approach to Managing Patients with Newly Diagnosed High-Risk Multiple Myeloma
    Naimisha Marneni
    Rajshekhar Chakraborty
    Current Hematologic Malignancy Reports, 2021, 16 : 148 - 161
  • [34] Real-world Outcomes of Chinese patients with high-risk Multiple Myeloma
    Sui Weiwei
    Deng, Shuhui
    An, Gang
    Xu, Yan
    Hao, Mu
    Mao, Xuehan
    Zou, De-Hui
    Qiu, Lugui
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E222 - E222
  • [35] Current Approach to Managing Patients with Newly Diagnosed High-Risk Multiple Myeloma
    Marneni, Naimisha
    Chakraborty, Rajshekhar
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (02) : 148 - 161
  • [36] High-Risk Multiple Myeloma Patients Are Missed without Gene Expression Profiling
    Van Vliet, Martin H.
    Chen, Yan-Ting
    Van Beers, Erik H.
    Kuiper, Rowan
    Valent, Erik T.
    Spaan, Marieke
    Terragna, Carolina
    Zamagni, Elena
    Cavo, Michele
    Oliva, Stefania
    Larocca, Alessandra
    Haferlach, Torsten
    Chng, Wee-Joo
    Waage, Anders
    Duin, M.
    Sonneveld, Pieter
    BLOOD, 2020, 136
  • [37] Spinal metastases in multiple myeloma: A high-risk subgroup for ISS III patients
    Cossu, Giulia
    Terrier, Louis-Marie
    Benboubker, Lotfi
    Destrieux, Christophe
    Velut, Stephane
    Francois, Patrick
    Zemmoura, Ilyess
    Amelot, Aymeric
    SURGICAL ONCOLOGY-OXFORD, 2018, 27 (02): : 321 - 326
  • [38] Bortezomib-Based Induction Treatments Improve Outcomes of Newly Diagnosed Multiple Myeloma Patients with High-Risk Cytogenetic Abnormalities
    Cavo, Michele
    Bringhen, Sara
    Terragna, Carolina
    Omede, Paola
    Marzocchi, Giulia
    Ruggeri, Marina
    Durante, Sandra
    Petrucci, Maria Teresa
    Guglielmelli, Tommasina
    Benevolo, Giulia
    Montefusco, Vittorio
    Narni, Franco
    Falcone, Antonietta
    Califano, Catello
    Baraldi, Anna
    Pasini, Silvana
    Galieni, Piero
    Morabito, Fortunato
    Grasso, Mariella
    Gottardi, Daniela
    Rizzo, Vincenzo
    Boccadoro, Mario
    Testoni, Nicoletta
    Palumbo, Antonio
    BLOOD, 2010, 116 (21) : 342 - 343
  • [39] Characterizing Treatment Patterns in Multiple Myeloma Patients with High-Risk Cytogenetics: A 15-Year-Study
    Uenkatesh, Priyanka
    Rahman, Raeef L.
    Khaliq, Aroog
    Laharwal, Mehak M.
    Atrash, Shebli
    Mcguirk, Joseph P.
    Lutfi, Forat
    Mushtaq, Muhammad Umair
    Abdallah, Al-Ola
    Ahmed, Nausheen
    Mewawalla, Prerna
    Snyder, Jordan
    Mahmoudjafari, Zahra
    BLOOD, 2024, 144 : 6943 - 6944
  • [40] Effect of Proteasome Inhibitors and / or Immunomodulatory Drugs on the Risk of Early Death of 991 Newly Diagnosed Symptomatic Multiple Myeloma Patients: A Single Centre Retrospective Analysis
    Galli, Monica
    Paris, Laura
    Pavoni, Chiara
    Delaini, Federica
    Rambaldi, Alessandro
    BLOOD, 2017, 130
12345